Data / Form D filings / Bright Uro, Inc.
Bright Uro, Inc.: Form D filings
Bright Uro, Inc., a biotechnology company in Irvine, CA, filed 6 Form D notices with the SEC between 2023 and 2025. The latest, on September 5, 2025, reports $15 million sold of a $15 million offering to 35 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 GODDARD, Irvine, CA, 92618
- Phone
- (949) 590-0555
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2002648
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Amendment | $14,999,999 | $14,999,999 | 35 | Jun 20, 2025 | sec.gov | |
| Jul 3, 2025 | New notice | $14,878,400 | $14,700,754 | $177,646 | 29 | Jun 20, 2025 | sec.gov |
| Jul 3, 2025 | Amendment | $32,053,460 | $31,024,760 | $1,028,700 | 108 | Nov 14, 2023 | sec.gov |
| Sep 23, 2024 | Amendment | $32,053,460 | $29,289,398 | $2,764,062 | 155 | Nov 14, 2023 | sec.gov |
| May 10, 2024 | Amendment | $29,963,483 | $20,139,794 | $9,823,689 | 108 | Nov 14, 2023 | sec.gov |
| Dec 5, 2023 | New notice | $22,963,500 | $12,963,499 | $10,000,001 | 56 | Nov 14, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Frazzette | Director | |
| Kevin Hershberger | Executive Officer | |
| Derek Herrera | Executive Officer, Director | |
| Sherman Williams | Director | |
| Kurt Azarbarzin | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 1, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Bright Uro, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.